Geneoscopy Inc., a US-based life sciences company, announced on Monday that it has named Haytham Gareer, MD, PhD as its new chief medical officer.
Dr Gareer is a trained surgical oncologist and has two decades of medical and clinical affairs experience. He has held the position of vice president, global head of Medical and Clinical Affairs for Olympus Corporation. He has served as a practicing surgeon and endoscopist with international experience in Egypt, Italy, and Japan.
Dr Gareer has acquired his MD in surgical oncology from Cairo University, National Cancer Institute, Egypt, and a Ph.D. in Surgical Sciences and Hepatobiliary and Pancreatic Illnesses from the University of Verona, Italy. He holds a Masters in Minimal Invasive Surgical Technology degree from Italy, an MBA from Hult International Business School, and is currently completing a Masters in Applied Healthcare Economics and Outcomes Research from Jefferson University.
GSK releases decade-long data on Shingrix efficacy
GSK announces positive EAGLE-1 results for gepotidacin in gonorrhoea treatment
Boehringer Ingelheim reports strong growth in 2023 and accelerates late-stage pipeline
Charles River Laboratories launches AMAP to reduce animal testing reliance
PureTech completes enrollment in Phase 2b ELEVATE IPF trial for LYT-100
Cybin secures additional US patent for CYB003 breakthrough therapy programme
UroGen's UGN-103 IND accepted by FDA for bladder cancer treatment
Biophytis reinforces obesity IP with new patent application
MaaT Pharma reveals positive 18-month data for MaaT013 in GI-aGvHD
Fusion Antibodies plc secures contract for OptiPhage library development
Innate Pharma advances Sanofi-developed NK cell engager to Phase 2 for blood cancer patients